New studies on Omicron provide more insight on COVID variant
New studies out of South Africa and the U.K. suggest the Omicron variant is less likely to cause hospitalizations — but it can still be deadly. The FDA also authorized a new antiviral pill to treat COVID-19. CBS News’ Nancy Chen reports on the latest, and then Dr. Amesh Adalja, an infectious disease expert at Johns Hopkins University Bloomberg School of Public Health, spoke with Jessi Mitchell on CBSN about the Omicron research and how some patients are experiencing different symptoms than earlier strains.
CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.
Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews
Watch CBSN live: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: http://facebook.com/cbsnews
Follow CBS News on Twitter: http://twitter.com/cbsnews
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact: licensing@veritone.com
